Offices – Switzerland
Explore all Offices
Global Reach
Global Reach

Apart from offering expert legal consultancy for local jurisdictions, CMS partners up with you to effectively navigate the complexities of global business and legal environments.

Explore our reach
Insights – Switzerland
Explore all insights
Expertise
Insights
Insights

CMS lawyers can provide future-facing advice for your business across a variety of specialisms and industries, worldwide.

Explore topics
Offices
Global Reach
Global Reach

Apart from offering expert legal consultancy for local jurisdictions, CMS partners up with you to effectively navigate the complexities of global business and legal environments.

Explore our reach
CMS Switzerland
Insights
About CMS

Select your region

Publication 28 Jul 2021 · Switzerland

CMS On the Pulse episode #8: A legal overview on public procurement for the Life Sciences & Healthcare sector

1 min read

On this page

Nick Beckett speaks with Virginie Dor (CMS Belgium), Bernt Elsner (CMS Austria) and Caroline Hobson (CMS UK).

In this episode, we discuss:

  • the importance of public procurement in the Healthcare sector, representing approximately 10% of GDP in the E.U.
  • the challenges for public procurement in extreme and unforeseen emergencies, including COVID-19
  • the scrutiny of direct awards and potential legal challenges and sanctions
  • the joint centralised procurement of vaccines in short timeframes and the benefits and pitfalls of such approach
  • in what circumstances exclusivity, including due to IP rights or technical barriers, can justify derogation from public procurement procedures
  • what changes do U.K. companies face in public procurement procedures in the E.U., and vice versa, in light of Brexit

Watch the video

Episode #8 - Public Procurement

Listen to the podcast

CMS Public Procurement Remedies Toolbox

previous page

7 CMS On the Pulse episode #7: Telemedicine law, regulations and developments

next page

9 CMS On the Pulse episode #9: A focus on compulsory licensing for pharmaceutical companies